About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Addressing Treatment Nonresponders | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingPhase 2NCT05921227

Addressing Treatment Nonresponders

The goal of this clinical trial is to see if providing late talking toddlers who are not responding to the Vocabulary Acquisition and Usage for Late Talkers (VAULT) treatment with a different way of c...

Lead sponsor: University of Arizona•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Mary Alt, PhD

CONTACT

520-626-6180 malt@arizona.edu

Nora Evans-Reitz, m

CONTACT

520-626-6885 nevansreitz@arizona.edu

Sponsors

Lead Sponsor

University of Arizona

Collaborators

National Institute on Deafness and Other Communication Disorders (NIDCD)

Children will begin Vocabulary Acquisition and Usage for Late Talkers (VAULT) word learning treatment. If, after three sessions, they do not show an initial response to treatment, they will be provided with a Big Mack Augmentative and Alternative Communication device which will allow them to 'say' the treatment words with the device. Treatment will continue until the children have had 8 total weeks of treatment (2x/wk for 30 minutes per session). The investigators will measure word learning across time tracking both spoken productions and productions made with the device.

Age

2 - 4 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Native English Speaking
•Pass pure tone hearing screening or medical report of normal hearing
•2-3 years at start of study
•MacArthur-Bates Communicative Development Inventories (MCDI) expressive scale \<10th percentile

Exclusion Criteria

•Parental report of other diagnoses
•Enrolled in concurrent treatment elsewhere
•Nonverbal IQ \<75 as measured by the Bayley Scales
•Parents unable to consistently bring child to treatment sessions.

Related studies

The Effect of Semantic Support on Word Learning

NCT05921214 · Language Development Disorders

Kindergarten Children Acquiring Words Through Storybook Reading

NCT03586479 · Language Development Disorders

COMPLETEDPhase 2

The Effect of Prior Learning on Word Learning

NCT05921188 · Language Development Disorders

Evaluation of an Early Support Programme in Orthophony

NCT04384328 · Language Development Disorders, Preterm Birth

Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder

NCT04926311 · Language Development Disorders, Speech and Language Disorder, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 30, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhasePHASE2

Enrollment16

Start dateJun 2026

Last updatedJul 30, 2025

Condition

Language Development Disorders

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 30, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions